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http:WHAT THIS PAPER ADDS
This review provides an overview of the current scarce literature on treatment of extracranial carotid artery
aneurysms (ECAAs). This review for the ﬁrst time identiﬁes a shortcoming of guidance for treatment of patients
presenting with ECAA. There is a clear lack of knowledge on the natural course of these aneurysms. Speciﬁc
essential details on etiology and aneurysm conﬁguration, size, and volume are currently insufﬁciently available.
Furthermore, deﬁning treatment indications for both surgical and endovascular intervention is not possible due
to the low quality of studies and confounding by indication. This review supports the need for an international
multicenter registry to reveal the optimal treatment for ECAA.Introduction: Aneurysms of the extracranial carotid artery (ECAA) are rare. Several treatments have been
developed over the last 20 years, yet the preferred method to treat ECAA remains unknown. This paper is a
review of all available literature on the risk of complications and long-term outcome after conservative or
invasive treatment of patients with ECAA.
Methods: Reports on ECAA treatment until July 2014 were searched in PubMed and Embase using the key words
aneurysm, carotid, extracranial, and therapy.
Results: A total of 281 articles were identiﬁed. Selected articles were case reports (n ¼ 179) or case series
(n ¼ 102). Papers with fewer than 10 patients were excluded, resulting in the ﬁnal selection of 39 articles
covering a total of 1,239 patients. Treatment consisted of either conservative treatment in 11% of the cases or
invasive treatment in 89% of the cases. Invasive treatment comprised surgery in 94%, endovascular approach in
5%, and a hybrid approach in 1% of the patients. The most common complication described after invasive
therapy was cranial nerve damage, which occurred in 11.8% of patients after surgery. The 30 day mortality rate
and stroke rate in conservatively treated patients was 4.67% and 6.67%, after surgery 1.91% and 5.16%.
Information on confounders in the present study was incomplete. Therefore, adjustments to correct for
confounding by indication could not be done.
Conclusions: This review summarizes the largest available series in the literature on ECAA management. The
number of ECAAs reported in current literature is scarce. The early and long-term outcome of invasive treatment
in ECAA is favorable; however, cranial nerve damage after surgery occurs frequently. Unfortunately, due to
limitations in reporting of results and confounding by indication in the available literature, it was not possible to
determine the optimal treatment strategy. There is a need for a multicenter international registry to reveal the
optimal treatment for ECAA.
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Invasive treatment for extracranial carotid artery aneurysms
(ECAAs) pertains to only 0.6e3.8% of all extracranial carotid
interventions,1e13 0.6e2% of all carotid endarterec-
tomies,3,5,7,10 and 0.4e2% of all extracranial arterial
142 J.C. Welleweerd et al.aneurysm repairs.14e16 A substantial portion of the ECAAs
will probably remain clinically silent. However, ECAAs may
lead to neurologic symptoms including transient ischemic
attacks (TIAs) or ischemic stroke.17e19 Other symptoms
include pulsating mass and related cranial nerve dysfunc-
tion (CND). Information regarding the natural history, in-
dications, and the best treatment in patients with ECAAs is
scarce and guidelines are lacking. Both medical, surgical,
and endovascular treatment of the aneurysm have been
recommended.14,15,18,20 The best medical treatment com-
prises antithrombotic treatment and regular follow up and
may have a place in the treatment of asymptomatic pa-
tients. Traditional surgical treatment, which is the current
treatment of choice of symptomatic or growing ECAAs,
consists of open resection of the entire aneurysm with or
without arterial replacement with an interposition
graft.14,20e22 However, this approach has been associated
with the risk of stroke and cranial nerve damage.23 Endo-
vascular ECAA repair has only been described in small case
series.23
For a proper assessment about which treatment should
be preferred, a better insight into natural history and risk of
complications of the different treatments is needed. This
paper is a review of all available literature on the risk of
complications and long-term outcome after conservative or
invasive treatment of patients with ECAA.
METHODS
Search strategy
In July 2014 a search was performed of all literature since
1900 in Medline (with Pubmed as interface) and Embase
combining the following search terms: aneurysm, carotid,
extracranial, therapy (and all synonyms for all treatment
options). The search was performed according to the search
strategy and data collection guidelines of the Meta-analysis
of Observational Studies in Epidemiology (MOOSE) Group.24Deﬁnition of ECAA
Because no generally accepted deﬁnition of ECAA exists, all
aneurysms deﬁned as such by the authors of the parent
paper, regardless of the deﬁnitions used, located in the
internal carotid artery (ICA) or in the common carotid artery
(CCA) were included. Only aneurysms located between the
CCA origin at the aortic arch and base of the skull were
included.Selection of studies
Retrieved records were independently screened by two
authors (J.W., G.B.) on title, abstract, and full text. All dis-
crepancies (3%) were discussed until ﬁnal agreement was
reached. If necessary, a third opinion could be obtained, but
agreement between authors was reached in all papers. In-
clusion criteria were (a) adult patients with an ECAA; (b)
description of the type of intervention (conservative treat-
ment, surgery, endovascular treatment, or any combina-
tion); (c) report of data on outcome during follow up (casefatality, fatal or non-fatal stroke, or local cervical symp-
toms); and (d) series describing 10 patients or more.
Language of publications was restricted to Dutch and
English. Studies regarding aneurysms located at the level of
the skull base or above, aneurysms located in the external
carotid artery (ECA), non-human data, and unavailable full
text papers were excluded. Studies presenting data at a
group level containing the ECA were included because of
the low number of ECAs in these series and the relevance to
present these large series.12,19,25e27 The reference list of all
selected articles was hand searched to retrieve additional
studies. Selected studies were critically appraised based on
study design, study quality, consistency, and directness
using the GRADE system.28 Subsequently, the level of evi-
dence of the studies was graded by one author (J.W.). The
level was graded high, moderate, low, or very low.
Data extraction
Three authors (J.W., B.N., G.B.) independently extracted
data by means of predeﬁned parameters. Individual patient
data were obtained when available. The following data were
retrieved: publication year, country of origin, number of
patients, study design, patient characteristics (age, gender,
history of smoking, diabetes, hypertension, and hyperlipid-
emia), aneurysm characteristics (affected vessel, exact
location, aneurysm shape, affected side, and aneurysm
size), etiology, and detailed method of treatment.
Outcome measurements included case fatality, stroke,
and local cervical symptoms. Local cervical symptoms are
deﬁned as any symptom, most likely related to the aneu-
rysm, in the cervical region on the ipsilateral side of the
aneurysm. Local cervical symptoms were scored as reported
by authors. Furthermore, any neurological deﬁcit with an
acute onset persisting for at least 24 hours for which no
other cause could be found was considered a stroke. Early
complications included all events that occurred within 30
days after intervention, or after detection of the ECAA in
patients who received conservative treatment. Late
outcome consisted of death from any cause and any stroke
that occurred after at least 30 days.
Statistical analyses
A pooled or summary estimate of the risk of all cause
mortality and of all and non-fatal strokes across all studies
was calculated together with a 95% conﬁdence interval
using a random effects model. The heterogeneity in results
among studies was evaluated by I2 statistics and by pre-
diction intervals. A 95% prediction interval shows the likely
range of values for the risks than can be expected if a new
and large study would be performed similar to those
included in this review. The prediction interval provides
insight into the variability or consistency between the re-
sults of individual studies whereas a 95% conﬁdence in-
terval around the pooled estimates provides insight into
how certain we are about the signiﬁcance of the pooled
estimate. The amount of between study variation (tau-
squared value of a random effects model) is a key factor
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values of between study variation will result in a large
prediction interval, even if a large number of studies is
included in a review.29
RESULTS
After removing duplicates, the search identiﬁed 3,711 articles
(Fig. 1). Following screening of title, abstract, and full text,
278 articles were selected. Hand searching the reference lists
of selected articles revealed threemore articles, resulting in a
ﬁnal selection of 281 articles. Selected articles were case
reports (n¼ 179) or case series (n¼ 102). Exclusion of papers
with fewer than 10 patients resulted in the ﬁnal selection of
39 articles on a total of 1,239 patients (a complete list of all
included articles can be found in the Appendix I).1e4,
6e8,11,12,14e16,18,19,25e27,30e51 The level of evidence from 23
studies was graded low and 16 records very low.
Patient and aneurysm characteristics
At presentation, 1,150 aneurysms (87%) were symptomatic,
476 (36%) presented with cerebral ischemia (120 strokes,Figure 1. Literature s291 TIAs, and in 56 patients cerebral ischemia was not
further speciﬁed). Other symptoms at presentation were a
cervical mass, a hematoma or rupture, pain or CND
(Table 1, Fig. 2).
Aneurysm size was deﬁned, by only two reports, as a
localized increase of the caliber in the carotid artery of
more than 50% compared to reference values or to the
expected vessel diameter.2,8
The main cause of the ECAA was atherosclerotic disease,
followed by trauma, but for 275 aneurysms (21%) no spe-
ciﬁc cause was given (Table 1, Fig. 2). Most aneurysms, 608
(46%), were located in the ICA (Table 1, Fig. 2). Since in-
formation on aneurysm shape was missing in over 50% of
cases this item was not reported in this paper.Treatment
A minority of aneurysms, 145 (11%), was treated without an
invasive intervention (Table 2). Invasive treatment consisted
of surgery in 1,102 (94%) aneurysms, endovascular treat-
ment in 57 (5%) aneurysms, or a combined approach in 18
(1%) (Table 2).earch ﬂow chart.
Table 1. Aneurysm characteristics.
Variables N (%)
Reports included 39
Patients 1239
Aneurysms 1322
Etiology
Atherosclerosis 509 38
Traumatic 144 11
Mycotic 65 5
Other 329 25
Not reported 275 21
Symptomsa
Cerebral ischemia 476 36
Mass 442 33
Asymptomatic 172 13
Compression 119 9
Local pain 39 3
Other 185 14
Location
ICA 608 46
Bifurcation 261 20
CCA 108 8
ECA 9 1
Not reported 336 25
Note. Other etiology includes granulomatous diseases, connective
tissue disorders, iatrogenic aneurysms, post carotid
endarterectomy cystic medial necrosis, and arteritis.
ICA ¼ internal carotid artery; CCA ¼ common carotid artery;
ECA ¼ external carotid artery.
a Some patients experienced multiple symptoms from one
aneurysm.
Figure 2. Symptoms at presentation, etiology and location of the
extracranial carotid artery aneurysms. ICA ¼ internal carotid ar-
tery; CCA ¼ common carotid artery; ECA ¼ external carotid artery.
Table 2. Treatment details.
Intervention n
Conservative
therapy
Anticoagulant therapy 24
No therapy 6
Medical management n.s. 2
Antiplatelet therapy 1
Conservative therapy n.s. 112
Endovascular
treatment
Stent placement 22
Balloon exclusiona 9
Stent placement with coil embolization 6
Embolization 1
Endovascular n.s. 19
Surgery Resection with interposition graft 376
Resection with direct anastomosis 264
Partial resection with reconstruction 107
Ligation 61
Aneurysmorraphy 34
ECA to ICA transposition 11
Bypass 39
Surgery n.s. 210
Combined
approach
Combined approach n.s. 16
ECIC bypass with balloon occlusiona 2
n.s. ¼ not speciﬁed; ECA ¼ extracranial carotid artery;
ICA ¼ internal carotid artery; ECIC ¼ extracranialeintracranial.
a In this procedure a balloon is placed (and left behind) in the
aneurysm or parent vessel. Balloon occlusion may also be
accompanied with concomitant ECIC bypass.
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In total 24 (2.05%, 95% CI 1.14e3.57) patients died, of
whom 13 had a stroke (5.04%, 95% CI 3.81e6.62), and 34
(3.05%, 95% CI 1.97e4.70) had a non-fatal stroke within 30
days (Table 3). The pooled estimate of the risk of all cause
mortality and of all and non-fatal strokes across all studies
describing conservative and surgical treatment are reported
in Table 3. The pooled estimates could not be calculated for
the endovascular and combined approach due to low study
numbers. CND occurred in 110 (12%) patients after surgery
and was never reported after endovascular treatment or
combined surgical and endovascular treatment.Long-term outcome
Follow up duration was most often presented as a mean
follow up of the study population and patients lost to follow
up was not reported in the majority. Therefore, it is not
possible to present the number of patients available for
follow up or the exact duration. During follow up 81 pa-
tients died, of whom eight had a fatal stroke, and 11 had a
non-fatal stroke. Most deaths (n ¼ 68, 83%) were reported
as not aneurysm related.Confounding by indication
An important issue considered in the evaluation of which
treatment option is superior using observational data is con-
founding by indication. Patients with certain characteristics
Table 3. Treatment outcome.
n 30 day mortality, % (95% CI) 30 day stroke, % (95% CI) 30 day non-fatal stroke, % (95% CI)
Conservative 39 4.67 (0.60e28.42) 6.67 (2.17e18.73) 2.22 (0.31e14.16)
Surgery 934 1.91 (1.01e3.57) 5.16 (3.94e6.73) 4.15 (3.07e5.59)
Overall 988 2.05% (1.14e3.63) 5.04 (3.81e6.62) 3.05 (1.97e4.70)
The data of the following articles was not included in this analysis because the data could not be split for the different interventions:
Higashida et al.,38 Aleksic et al.,30 De Jong et al.,35 McCollum et al.,15 Padayachy and Robbs,41 Frankhauser et al.27
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could be associated with a worse or beneﬁcial outcome. For
correcting confounding by indication, completeness of po-
tential confounders is needed. However, information on
confounders in the present study is far from complete and
could not be retrieved from the papers. Therefore, adjust-
ments could not be made and therefore, no valid comparison
of outcome for the four different treatments was possible.
DISCUSSION
ECAAs are rare, leading to retrieval of only 39 case series
containing 10 or more patients. Early mortality and number
of strokes is low in surgical and endovascular treatment.
Furthermore, the long-term follow up demonstrates low
stroke numbers in both intervention groups, which supports
the assumption that invasive treatment could prevent
stroke. These ﬁndings are in line with other publica-
tions.2,14,23 The high CND in surgically treated patients is
probably related to the distal location of aneurysms in the
ICA and to the extensive dissection needed to perform
complete aneurysm resection. The available information on
ECAA treatment in the literature suffers greatly because of
its rarity, from small case series, missing data, publication
bias, and confounding by indication. Furthermore, the level
of evidence in the available literature is low to very low;
therefore, any estimate of effect based on these records is
very uncertain. Therefore, no evidence based recommen-
dation can be given for an individual patient with an ECAA.
The natural course of ECAAs is still hardly understood.
Since knowledge of the natural course is required to bal-
ance the beneﬁt of any type of intervention, thus far no
treatment guideline or expert consensus for the manage-
ment of ECAA has been developed. Probably, the main goal
in the management of ECAAs is to prevent thrombo-
embolic complications of the aneurysm. In aneurysms in
other vascular territories, size is often used as an indication
for intervention. Aneurysm size may probably be most
related to aneurysm rupture. However, rupture is consid-
ered very unusual in ECAAs, and most surgeons may only
intervene in patients with thrombo-embolic symptoms or
proven progressive ECAA growth.
Medical therapy in ECAAs, including medication choice,
remains unexplored and needs to be further investigated.
However, ECAAs can occur after dissection in the carotid
artery or in patients with generalized atherosclerotic dis-
ease. In these diseases, medical therapy has long been used
and is scientiﬁcally substantiated. Following the medical
treatment guidelines for the most probable underlying
disease is recommended until more evidence is available
regarding medical treatment in ECAA patients.Operative therapy has been advocated for any ECAA
because of the high mortality risk in non-operated
cases.15,18,20,22 Nowadays, small case series advocating an
endovascular approach to treat ECAA have reported favor-
able procedural results but with a limited number of cases
and no mid- or long-term follow up.23,52 Endovascular
treatment with a stent may be the most favored option of
the invasive treatments, mainly because of a high preva-
lence of CND associated with surgical treatment.
Although the approach of this study allowed presentation
of early and late outcomes of ECAA treatment, the present
study has several limitations. First of all, no randomized
controlled trials have been published on ECAA treatment,
and data for the present analysis were obtained from case
series only. Inherently, the assessment was limited to infor-
mation provided in these articles resulting in a high rate of
missing data. The reported rates for neurological complica-
tions may be biased because none of the studies performed
independent and structured conﬁrmation of these events.
Furthermore, publication bias may have occurred while case
series regularly present only striking and/or invasively
treated cases. Another disadvantage is that physicians may
tend to publish successful rather than unsuccessful cases.
However, by excluding small case series the risk of publication
bias was reduced. Because of this publication bias, the results
of this study may not be generalizable to the ECAA popula-
tion. In addition, since this was an observational study, the
baseline characteristics of the patients undergoing different
treatments were not completely identical. In this study there
was confounding by indication because treatment choicewas
based on patient and aneurysm characteristics. Some of
these characteristics may give rise to a different prognosis.
Unfortunately, due to incomplete data and low patient
numbers, this confounding by indication could not be cor-
rected and comparison between treatment outcomes for the
different treatment groupswas not possible. Because in 31 of
39 studies the data were presented at a group level, per-
forming any sub-analyses was not possible.
The present study does represent the largest evaluation
of treatment in patients with an ECAA. This review for the
ﬁrst time clearly shows the lack of knowledge on the natural
course of ECAAs, and the fact that population based
reporting makes it impossible to perform an individualized
patient data analysis. To gain more accurate information
regarding the prognosis and results of both conservatively
and invasively treated ECAAs more research is needed.
Initiating a randomized controlled trial is not feasible
because of the low incidence of ECAAs and the low case
fatality rates, but more knowledge regarding natural history
and treatment indications might be obtained from a well
146 J.C. Welleweerd et al.designed prospective study. Consequently, the authors have
designed a prospective web-based international registry to
collect data on ECAA (www.carotidaneurysmregistry.com).53
CONCLUSION
This review summarizes the largest available series in the
literature on ECAA treatment. The few data consist of a mix
of conservative, open surgical, and a growing number of
endovascular interventions. There is no consensus in ECAA
treatment. The early and long-term outcome of invasive
treatment in ECAA is favorable; however, cranial nerve
damage after surgery occurs frequently. This review sup-
ports the need for an international multicenter registry to
reveal the optimal treatment for ECAA.
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